|
Thursday, 31 July 2008 |
|
However, in order to choose the right kind of cosmetic for your skin care, you need to do a bit of research about your skin type whether it is normal, dry, oily, sensitive, combination, dull or mature. You also need to consider your skin’s complexion while purchasing cosmetics. |
|
Read more...
|
|
|
Monday, 21 July 2008 |
|
Also popularly known as phototricholysis or photoepilation, laser hair removal has become very popular in the contemporary times. The main methodology behind it is ‘selective photothermolysis’; wherein laser is done on the chosen area while making sure the rest of the skin does not get heated. |
|
Read more...
|
|
|
Wednesday, 09 July 2008 |
|
Every women requires to take care of their skin on a regular basis, so they can maintain their beauty and avoid the dangers of the environment toxins that can make imperfections or wrinkles in your skin. |
|
Read more...
|
|
|
Wednesday, 30 April 2008 |
|
When one thinks of the injuries sustained by baseball players, skin irritation is not certainly the malady that jumps to mind. |
|
Read more...
|
|
|
Friday, 11 April 2008 |
|
Many of us when confronted with an acne pimple on our faces may well decide to pop it. That would be a foolish move. The act of popping an acne pimple encourages the spread of the bacteria and other irritants inside that same pimple. The affected skin might then trigger an inflammatory response. |
|
Read more...
|
|
|
Thursday, 10 April 2008 |
|
Schering-Plough Corporation announced that the European Commission (EC) has adopted a Decision approving an addition of one therapeutic indication of AERIUS® (desloratadine) for the recent European Union (EU) 27 member states as well as Iceland and Norway. |
|
Read more...
|
|
|
Wednesday, 09 April 2008 |
|
New study results released by the American Society for Dermatologic Surgery (ASDS) show the top procedures performed by dermasurgeons are skin cancer repair and reconstruction surgeries. |
|
Read more...
|
|
|
Wednesday, 09 April 2008 |
|
Even though at least 50% of adults suffer from some type of adult acne, society has not given that regular medical difficulty a valuable deal of attention. While changing hormone levels are commonly associated with teenagers, the hormones of the adult also undergo changes. |
|
Read more...
|
|
|
Tuesday, 08 April 2008 |
|
A new study presented at the Experimental Biology Annual Meeting shows that a proprietary blend extracted from canola, Dermytol(TM), creates a pronounced reduction of malignant melanoma cell growth. Dermytol(TM), a proprietary compound developed by KGK Synergize Inc. |
|
Read more...
|
|
|
Saturday, 05 April 2008 |
|
In the first comprehensive study of the genetic basis of psoriasis, researchers at Washington University School of Medicine in St. Louis have discovered seven new sites of general DNA variation that increase the risk of the troublesome skin condition. |
|
Read more...
|
|
|
Friday, 04 April 2008 |
|
ZAPZYT® Skin Care Products, distributed by Waltman Pharmaceuticals, Inc., an industry leader in the battle against teen acne, is now ingoing the adult acne category with the launch of Adult Acne Clearing Gel by ZAPZYT®. |
|
Read more...
|
|
|
Friday, 04 April 2008 |
|
Results of an independent multi-treatment clinical study of the UltraShape(R) Contour I, the first clinically proven non-invasive solution for fat reduction and body contouring using non-thermal selective focused ultrasound will be presented at the American Society for Laser Medicine and Surgery... |
|
Read more...
|
|
|
Thursday, 03 April 2008 |
|
Seven new sites of general DNA variation have been discovered that increase the risk of psoriasis. Some of these variations, in one area of the genome, link psoriasis and psoriatic arthritis to other autoimmune disorders. |
|
Read more...
|
|
|
Thursday, 03 April 2008 |
|
Rhytec, Inc. |
|
Read more...
|
|
|
Tuesday, 01 April 2008 |
|
DUSA Pharmaceuticals, Inc.(R) (NASDAQ GM:DUSA), is pleased to announce that the acne Phase IIb trial has achieved its goal of 260 participants, hence completing enrollment. |
|
Read more...
|
|
|
Wednesday, 26 March 2008 |
|
Anacor Pharmaceuticals announced results from a Phase 2a clinical trial of AN2728, an investigational topical anti-inflammatory drug, in patients with psoriasis. The study met its primary endpoint and all secondary endpoints. |
|
Read more...
|
|
|
Wednesday, 26 March 2008 |
|
Home Skinovations Ltd. announced that the Silk'n™ device was cleared by the United States Food and Drug Administration (FDA) for home-based removal of unwanted hair under the course of a physician. |
|
Read more...
|
|
|
Tuesday, 25 March 2008 |
|
An isolated, innate Romanian community has a higher than average frequency of the skin disease vitiligo and other autoimmune diseases, suggesting a genetic variation that may indicate susceptibility to the condition in a broader population, according to a report in the March issue of Archives of... |
|
Read more...
|
|
|
Tuesday, 25 March 2008 |
|
A traditional Chinese herbal medicine consisting of five herbs may benefit people with eczema, new research in the British Journal of Dermatology will disclose. |
|
Read more...
|
|
|
Saturday, 22 March 2008 |
|
Baxter Healthcare Corporation announced the U.S. Food and Drug Administration (FDA) approval of ARTISS (Fibrin Sealant (Human)), the first and only slow-setting fibrin sealant indicated for use in adhering skin grafts in adult and pediatric burn patients. |
|
Read more...
|
|
|
Friday, 21 March 2008 |
|
NanoBio Corporation has announced that it has seen promising results from an interim study of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details stay confidential, the results evidently justify completing the study, according to NanoBio scientists. |
|
Read more...
|
|
|
Friday, 21 March 2008 |
|
The U.S. Food and Drug Administration today accepted a new medical adhesive (a fibrin sealant) called Artiss for use in attaching skin grafts onto burn patients. Fibrin sealants are tissue adhesives that contain the proteins fibrinogen and thrombin, which are valuable in the clotting of blood. |
|
Read more...
|
|
|
Thursday, 20 March 2008 |
|
The New York Times on Wednesday examined a "migration" of "top tier" medical students from "branches of health care that manage major diseases toward specialties that advance the life of patients," like dermatology and plastic surgery, and that advance the "lives of physicians, with better pay,... |
|
Read more...
|
|
|
Wednesday, 19 March 2008 |
|
C1-esterase inhibitor (C1-INH) concentrate is a safe and effective therapy that fast relieves acute abdominal and facial swelling attacks in patients with hereditary angioedema (HAE), a infrequent and serious genetic disorder, according to data presented at the American Academy of Allergy, Asthma &... |
|
Read more...
|
|
|
Wednesday, 19 March 2008 |
|
|
|
Read more...
|
|
|
Tuesday, 18 March 2008 |
|
NanoBio Corporation reports that its randomized, double-blind, vehicle-controlled 2b study of NB-001, a topical lotion to treat herpes labialis (cold sores), met its primary and secondary endpoints by demonstrating clear efficacy and safety in 482 patients. |
|
Read more...
|
|
|
Saturday, 15 March 2008 |
|
Isolagen(TM), Inc. (Amex: ILE) announced the completion of enrollment of approximately 120 patients in its Phase II/III Study IT-A-008 investigating the Isolagen Therapy(TM) for the treatment of moderate to severe acne scars. |
|
Read more...
|
|
|
Friday, 14 March 2008 |
|
Glycotex, Inc. announced that it had completed patient enrollment in a Phase IIa study evaluating the effect of GLYC-101 on wound closure in patients undergoing carbon dioxide laser skin resurfacing. |
|
Read more...
|
|
|
Friday, 14 March 2008 |
|
CombinatoRx, Incorporated (NASDAQ: CRXX) announced top line results of its randomized, blinded, placebo-controlled Phase 2 proof-of-concept clinical trial of CRx-191 in plaque psoriasis. |
|
Read more...
|
|
|
Tuesday, 11 March 2008 |
|
Psoriasis patients should be routinely screened for the presence of potentially serious co-morbidities associated with the disease, investigators said here at a journalists workshop. |
|
Read more...
|
|